This topic contains a solution. Click here to go to the answer

Author Question: Infuse Zinacef 1.5 g IVPB in 50 mL D5W over 20 minutes. Drop factor is 20 gtt/mL. _____ a. 100 ... (Read 19 times)

frankwu

  • Hero Member
  • *****
  • Posts: 549
Infuse Zinacef 1.5 g IVPB in 50 mL D5W over 20 minutes. Drop factor is 20 gtt/mL. _____
 
  a. 100 gtt/min
  b. 50 gtt/min
  c. 40 gtt/min
  d. 30 gtt/min

Question 2

You find 150 mL of fluid left in an IV. The IV is infusing at 15 microdrops/min. How long will the IV fluid last? _______________
 
  a. 2 1/2 hr
  b. 2 hr
  c. 24 min
  d. 10 hr



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

efwsefaw

  • Sr. Member
  • ****
  • Posts: 351
Answer to Question 1

ANS: B

Answer to Question 2

ANS: D




frankwu

  • Member
  • Posts: 549
Reply 2 on: Jul 3, 2018
YES! Correct, THANKS for helping me on my review


shailee

  • Member
  • Posts: 392
Reply 3 on: Yesterday
Excellent

 

Did you know?

Hypertension is a silent killer because it is deadly and has no significant early symptoms. The danger from hypertension is the extra load on the heart, which can lead to hypertensive heart disease and kidney damage. This occurs without any major symptoms until the high blood pressure becomes extreme. Regular blood pressure checks are an important method of catching hypertension before it can kill you.

Did you know?

Critical care patients are twice as likely to receive the wrong medication. Of these errors, 20% are life-threatening, and 42% require additional life-sustaining treatments.

Did you know?

IgA antibodies protect body surfaces exposed to outside foreign substances. IgG antibodies are found in all body fluids. IgM antibodies are the first type of antibody made in response to an infection. IgE antibody levels are often high in people with allergies. IgD antibodies are found in tissues lining the abdomen and chest.

Did you know?

More than 2,500 barbiturates have been synthesized. At the height of their popularity, about 50 were marketed for human use.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library